Statins and cancer
This article was originally published in The Tan Sheet
Executive Summary
Cholesterol-lowering statins have shown a protective effect against colorectal cancer and should be investigated for such a benefit in future clinical trials, Jenny Poynter, MD, University of Michigan, et al., state in a research paper presented at the American Society of Clinical Oncology's Plenary Session in New Orleans June 7. The research evaluated data from the Molecular Epidemiology of Colorectal Cancer (MECC) study conducted in northern Israel between 1998 and 2002, which involved 1,608 patients with colorectal cancer and 1,734 controls. Release of the results follows publication of a study in the June 1 edition of Cancer concluding that statins may decrease the risk of breast cancer in post-menopausal women...
You may also be interested in...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.